acut segment lead way behavior
follow
ebitda beat better margins/top line promis
ebitda incl minor interest est/consensu
better expect rev margin store ss acut rev strong
sequenti full year averag solid
volum price ss psych rev slow grow vs
year despit strong ss adj admiss price pressur
on-going length stay lo pressur expect pressur psych biz
persist see settlement doj potenti catalyst improv
posit increas reserv settlement
impli increment progress toward settlement also provid guidanc
ebitda less nci slightli better margin roll
rais estim reflect strong guidanc reiter buy rate
rais po ebitda multipl higher est continu
expect rebound psych busi doj settlement approach conclus
chang volatil risk rate high medium
guid est better margin ep consensu
net revenu guidanc est/consensu
adj ebitda less nci guidanc compar
ests/consensu impli roughli margin expans adj ep
guidanc est/consensu expect capital-expenditure
model
ss margin segment tough acut comp
acut net rev estim better adj admiss
better revs/adj admit ss margin y/i vs
behavior net rev line estimate adj patient day came better
rev/adj patient day came wors margin suffer howev psych biz ss
margin vs expect solid perform acut
welcom wait doj settlement rebound behavior
full definit iqmethod sm measur see page
bofa merril lynch seek busi issuer cover research report
result investor awar firm may conflict interest could
affect object report investor consid report singl
factor make invest decis
refer import disclosur page analyst certif page price object
basis/risk page
net dbt
return capit employ
return equiti
iqmethod sm qualiti earn
net incom cont oper
chang work capit
full definit iqmethod sm measur see page
inc own oper
acut care hospit behavior health center
ambulatori surgeri radiat oncolog center
oper acut care hospit
behavior health facil us uk
believ pois see
reacceler psych busi near
depart justic doj settlement mid-
meanwhil exposur higher growth
acut care market allow perform
better averag wait psych
po base ebitda estim repres multipl
midpoint compani histor rang ebitda reflect better
expect perform behavior busi higher earn exposur
higher growth/return psych busi today histor period averag
upsid risk po larger expect demand tailwind behavior
busi addit unexpect feder fund behavior health program
exposur faster expect growth acut busi
downsid risk po continu delay psych rebound rise labor cost
gener weak backdrop util rise bad debt risk doj settlement
take much longer expect resolv much higher expect
kevin fischbeck cfa herebi certifi view express research report
accur reflect person view subject secur issuer also
certifi part compens directli indirectli relat
specif recommend view express research report
us facil hospit manag healthcar coverag cluster
qualiti earn
iqmethod smi set bofa merril lynch standard measur serv maintain global consist three broad head busi perform qualiti earn valid key featur
iqmethod consist structur detail transpar methodolog guidelin maxim effect compar valuat process identifi common pitfal
iqdatabas real-tim global research databas sourc directli equiti analyst earn model includ forecast well histor data incom statement balanc sheet cash
flow statement compani cover bofa merril lynch
iqprofil sm iqmethod sm servic mark america corpor iqdatabas regist servic mark america corpor
